Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management
|
July 2, 2019
Shingrix: A New Herpes Zoster Vaccine
Fraidy Maltz, Brooke Fidler
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 28, 2014
Ingenol mebutate gel (picato): a novel agent for the treatment of actinic keratoses
Brooke Fidler, Tamara Goldberg
P & T : a Peer-Reviewed Journal for Formulary Management
|
July 5, 2017
Eluxadoline (Viberzi): A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome With Diarrhea
Fraidy Maltz, Brooke Fidler
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 24, 2015
Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis
Tamara Goldberg, Brooke Fidler
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 3, 2017
Rolapitant (Varubi): A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Tamara Goldberg, Brooke Fidler, Stephanie Cardinale
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
P & T : a Peer-Reviewed Journal for Formulary Management
|
July 2, 2019
Shingrix: A New Herpes Zoster Vaccine
Fraidy Maltz, Brooke Fidler
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 28, 2014
Ingenol mebutate gel (picato): a novel agent for the treatment of actinic keratoses
Brooke Fidler, Tamara Goldberg
P & T : a Peer-Reviewed Journal for Formulary Management
|
July 5, 2017
Eluxadoline (Viberzi): A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome With Diarrhea
Fraidy Maltz, Brooke Fidler
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 24, 2015
Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis
Tamara Goldberg, Brooke Fidler
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 3, 2017
Rolapitant (Varubi): A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Tamara Goldberg, Brooke Fidler, Stephanie Cardinale
Page
of 1